Literature DB >> 10971057

Adamantiades-Behçet's disease: serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate.

J Katsantonis1, Y Adler, C E Orfanos, C C Zouboulis.   

Abstract

BACKGROUND: Interleukin 8 (IL-8) has recently been under focused investigation because of its possible participation in the evolution of Adamantiades-Behçet's disease.
OBJECTIVE: The reliability of IL-8 as a serological marker for the activity of the disease was investigated in a prospective consecutive trial of 34 cases.
METHODS: The activity of the disease was clinically evaluated by the number of actively involved organ systems registered on the day of blood sampling and by the presence of oral aphthous ulcers. Serum IL-8 levels were compared to C-reactive protein (CRP) values and the erythrocyte sedimentation rate.
RESULTS: An association of IL-8 levels with the activity of the disease was detected when compared with both the number of active clinical signs (p = 0.024) and the presence of oral aphthous ulcers (p = 0.002). In contrast, no association of CRP and sedimentation rate with the activity of the disease could be detected. A weak correlation of IL-8 levels with sedimentation rate values at 2 h was found (R = 0.37, p = 0.032).
CONCLUSION: Our results confirm previous data concerning the significance of IL-8 and, in addition, they provide first evidence for the reliability of IL-8 as a serological marker for assessment of the activity of Adamantiades-Behçet's disease in the follow-up of clinical and therapeutic studies. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971057     DOI: 10.1159/000018426

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  14 in total

Review 1.  Pathogenesis of Adamantiades-Behçet's disease.

Authors:  Christos C Zouboulis; Tobias May
Journal:  Med Microbiol Immunol       Date:  2003-03-05       Impact factor: 3.402

2.  Constitutive and LPS-induced expression of MCP-1 and IL-8 by human uveal melanocytes in vitro and relevant signal pathways.

Authors:  Dan-Ning Hu; Mingchao Bi; David Y Zhang; Fei Ye; Steven A McCormick; Chi-Chao Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

Review 3.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

Review 4.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

Review 5.  Etiopathogenesis of Behçet's disease with emphasis on the role of immunological aberrations.

Authors:  Violetta D Kapsimali; Meletios A Kanakis; George A Vaiopoulos; Phaedon G Kaklamanis
Journal:  Clin Rheumatol       Date:  2010-05-22       Impact factor: 2.980

6.  Plasma and whole-blood chemokine levels in patients with Behcet's disease.

Authors:  Toshikatsu Kaburaki; Yujiro Fujino; Hidetoshi Kawashima; Guillermo Merino; Jiro Numaga; Jun Chen; Kouji Matsushima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-23       Impact factor: 3.117

7.  Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease.

Authors:  Alzírton de Lira Freire; Manoel Barros Bertolo; Antônio José de Pinho; Adil Muhib Samara; Sandra Regina Muchinechi Fernandes
Journal:  Clin Rheumatol       Date:  2004-04-02       Impact factor: 2.980

8.  Peripheral neuropathy in Behçet disease: an electroneurophysiological study.

Authors:  Lale Akbulut; Gunes Gur; Hatice Bodur; Nuran Alli; Pinar Borman
Journal:  Clin Rheumatol       Date:  2006-12-06       Impact factor: 3.650

9.  Pharmacological Inactivation of Src Family Kinases Inhibits LPS-Induced TNF-α Production in PBMC of Patients with Behçet's Disease.

Authors:  Sevgi Irtegun; Gulsum Pektanc; Zeynep M Akkurt; Mehtap Bozkurt; Fatih M Turkcu; Sevgi Kalkanli-Tas
Journal:  Mediators Inflamm       Date:  2016-06-30       Impact factor: 4.711

10.  Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease.

Authors:  Giuseppe Lopalco; Orso Maria Lucherini; Antonio Vitale; Rosaria Talarico; Antonio Lopalco; Mauro Galeazzi; Giovanni Lapadula; Luca Cantarini; Florenzo Iannone
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.